Wentworth-Douglass Hospital
(603) 742-5252
Decrease (-) Restore Default Increase (+) font size
Physicians
myWDconnect Patient Portal
Pay Your Bill Online
Pricing Estimates
Financial Assistance
Health Library
Health Insurance Marketplace
Interpreter and Communication Services
Surgery Preparation
Medical Records
Accountable Care Organization
Advance Directives
Clinical Research & Trials
Food and Nutrition Services
Back to Health Library   Print This Page Print    Email to a Friend Email

Serotonin uptake
Serotonin uptake


Definition:

Carcinoid syndrome is a group of symptoms associated with carcinoid tumors -- tumors of the small intestine, colon, appendix, and bronchial tubes in the lungs.



Causes, incidence, and risk factors:

Carcinoid syndrome is the pattern of symptoms sometimes seen in people with carcinoid tumors. These tumors are rare, and often slow growing.

Carcinoid syndrome occurs only 10% of the time, usually after the tumor has spread to the liver or lung.

These tumors release too much of the hormone serotonin , as well as several other chemicals that cause the blood vessels to open (dilate).

More carcinoid tumors are being diagnosed today than in the past.



Symptoms:

Most carcinoid tumors have no symptoms. They only produce the syndrome about 10% of the time.

When symptoms do occur, they may include:

Sometimes symptoms are brought on by physical exertion, or eating or drinking things such as blue cheeses, chocolate, or red wine.



Signs and tests:

Most of these tumors are found during abdominal surgery.

A physical examination may show:

  • Heart valve lesions
  • Signs of niacin-deficiency disease (pellagra )

Tests may include:

  • 5-HIAA levels in urine
  • Blood tests (including serotonin blood test)
  • CT and MRI scan
  • OctreoScan (to identify most carcinoids and other neuroendocrine tumors)


Treatment:

Surgery to remove the tumor is usually the first treatment. It can permanently cure the condition if the tumor is completely removed.

If the tumor has spread to the liver, treatment involves destroying the local blood supply or giving chemotherapy directly into the liver.

When the entire tumor cannot be removed, removing large portions of the tumor ("debulking") can help relieve the symptoms.

Sandostatin (octreotide) injections are sometimes given to people with advanced carcinoid tumors that cannot be removed with surgery. This drug can block and reverse tumor growth. Interferon is often given with octreotide to help stop tumor growth.

A serotonin antagonist may be prescribed to control diarrhea and poor absorption of nutrients from the intestines (malabsorption ).

One of several combinations of chemotherapy may be given through a vein (IV) or by mouth. If one combination does not work, another combination may be effective. About one-third of patients benefit from chemotherapy.

Avoid alcohol, large meals, and foods high in tyramine (aged cheeses, avocado, many processed foods), because they may trigger symptoms.

Some common medicines, like selective serotonin reuptake inhibitors (SSRIs, such as Paxil, Serzone, and Prozac) may make symptoms worse by increasing levels of serotonin. However, do not stop taking these medicines unless your doctor tells you to do so.



Support Groups:

Learn more about carcinoid syndrome and get support from:



Expectations (prognosis):

The outlook in patients with carcinoid syndrome is different from the outlook in patients who have carcinoid tumors without the syndrome.

In people with the syndrome, the tumor has usually spread to the liver, which lowers the survival rate. People with carcinoid syndrome are also more likely to have a separate cancer (second primary tumor) at the same time.

The outlook is more favorable thanks to new treatment methods, such as Sandostatin.



Complications:

Calling your health care provider:

Call for an appointment with your health care provider if you have symptoms of carcinoid syndrome.



Prevention:

Treating the tumor reduces the risk of carcinoid syndrome.



References:

Kulke MH. Clinical presentation and management of carcinoid tumors. Hematol Oncol Clin North Am. 2007;21:433-455.

Robertson RG, Geiger WJ, Davis NB. Carcinoid tumors. Am Fam Physician. 2006.74:429-434.




Review Date: 9/4/2008
Reviewed By: Sean O. Stitham, MD, private practice in Internal Medicine, Seattle, Washington; and James R. Mason, MD, Oncologist, Director, Blood and Marrow Transplantation Program and Stem Cell Processing Lab, Scripps Clinic, Torrey Pines, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com


Find What You Need

Events
Careers
Foundation
About Us
Contact
Directions
News
Social Media Agreement
Joint Notice
Web Privacy Policy
WDH Staff Portal

Centers & Services

Cancer Center
Cardiovascular Care
Joint Replacement
Women & Children's
Physician Offices
Other Services

Conditions & Treatments

Health Library

Support Services

Support Groups
Care-Van
Dental Center
Social Work
Food & Nutrition
Integrative Wellness
Spiritual Care
Concerns & Grievances
Homecare and Hospice

For Patients

Pay Your Bill Online
Pricing Estimates
Financial Assistance
Interpreter Services
Surgery Preparation
Medical Record Request
Advance Directives
Clinical Research & Trials

For Healthcare Professionals

Work and Life
Financial Well-Being
Career and Growth

The Wentworth-Douglass Health System includes:

 

Address

Wentworth-Douglass Hospital
789 Central Avenue, Dover, NH 03820
Phone: (603) 742-5252
Toll free: 1 (877) 201-7100